DYADIC INTERNATIONAL INC Number of Operating Segments
DYADIC INTERNATIONAL INC (DYAI) reported Number of Operating Segments of 1 Segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfOperatingSegments · last filed 2026-08-12
- 2020-09-30: Number of Operating Segments 9 month 1.00 numberOfSegment.
numberOfSegment
| Period end | Number of Operating Segments 9 month |
|---|---|
| 2020-09-30 | 1.00 numberOfSegment 10-Q · filed 2020-11-12 |
pure
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2025-03-31 | 100.00% 10-Q · filed 2025-05-14 | |||
| 2024-12-31 | 100.00% 10-K · filed 2025-03-26 | |||
| 2024-09-30 | 100.00% 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | 100.00% 10-Q · filed 2024-08-13 | |||
| 2024-03-31 | 100.00% 10-Q · filed 2024-05-14 | |||
| 2023-12-31 | 100.00% 10-K · filed 2024-03-28 | |||
| 2023-09-30 | 100.00% 10-Q · filed 2023-11-08 | |||
| 2023-06-30 | 100.00% 10-Q · filed 2023-08-09 | |||
| 2023-03-31 | 100.00% 10-Q · filed 2023-05-10 | |||
| 2022-09-30 | 100.00% 10-Q · filed 2022-11-10 | |||
| 2022-06-30 | 100.00% 10-Q · filed 2022-08-10 | |||
| 2022-03-31 | 100.00% 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | 100.00% 10-K · filed 2022-03-29 | |||
| 2021-09-30 | 100.00% 10-Q · filed 2021-11-10 | |||
| 2021-06-30 | 100.00% 10-Q · filed 2021-08-12 | |||
| 2021-03-31 | 100.00% 10-Q · filed 2021-05-13 | |||
| 2020-12-31 | 100.00% 10-K · filed 2021-03-30 |
segment
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2020-06-30 | 1.00 segment 10-Q · filed 2020-08-13 | |||
| 2020-03-31 | 1.00 segment 10-Q · filed 2020-05-14 | |||
| 2019-12-31 | 1.00 segment 10-K · filed 2020-03-30 | |||
| 2019-09-30 | 1.00 segment 10-Q · filed 2019-11-13 | |||
| 2019-06-30 | 1.00 segment 10-Q · filed 2019-08-13 | |||
| 2019-03-31 | 1.00 segment 10-Q · filed 2019-05-09 | |||
| 2018-12-31 | 1.00 segment 10-K · filed 2019-03-27 |
Segment
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 Segment 10-Q · filed 2026-08-12 | |||
| 2026-03-31 | 1.00 Segment 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | 1.00 Segment 10-K · filed 2026-03-25 | |||
| 2025-09-30 | 1.00 Segment 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | 1.00 Segment 10-Q · filed 2025-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |